دورية أكاديمية

Management of Central Nervous System Infections, Vientiane, Laos, 2003-2011.

التفاصيل البيبلوغرافية
العنوان: Management of Central Nervous System Infections, Vientiane, Laos, 2003-2011.
المؤلفون: Dubot-Pérès, Audrey, Mayfong Mayxay, Phetsouvanh, Rattanaphone, Lee, Sue J., Rattanavong, Sayaphet, Manivanh Vongsouvath, Viengmon Davong, Vilada Chansamouth, Koukeo Phommasone, Moore, Catrin, Dittrich, Sabine, Lattana, Olay, Sirisouk, Joy, Phonelavanh Phoumin, Phonepasith Panyanivong, Sengduangphachanh, Amphonesavanh, Sibounheuang, Bountoy, Chanthongthip, Anisone, Simmalavong, Manivone, Sengdatka, Davanh
المصدر: Emerging Infectious Diseases; May2019, Vol. 25 Issue 5, p898-910, 13p
مصطلحات موضوعية: CENTRAL nervous system infections, JAPANESE encephalitis viruses, BACTERIAL meningitis, EMERGING infectious diseases, ETIOLOGY of diseases, GLASGOW Coma Scale
مصطلحات جغرافية: LAOS, VIANGCHAN (Laos)
مستخلص: During 2003-2011, we recruited 1,065 patients of all ages admitted to Mahosot Hospital (Vientiane, Laos) with suspected central nervous system (CNS) infection. Etiologies were laboratory confirmed for 42.3% of patients, who mostly had infections with emerging pathogens: viruses in 16.2% (mainly Japanese encephalitis virus [8.8%]); bacteria in 16.4% (including Orientia tsutsugamushi [2.9%], Leptospira spp. [2.3%], and Rickettsia spp. [2.3%]); and Cryptococcus spp. fungi in 6.6%. We observed no significant differences in distribution of clinical encephalitis and meningitis by bacterial or viral etiology. However, patients with bacterial CNS infection were more likely to have a history of diabetes than others. Death (26.3%) was associated with low Glasgow Coma Scale score, and the mortality rate was higher for patients with bacterial than viral infections. No clinical or laboratory variables could guide antibiotic selection. We conclude that high-dependency units and first-line treatment with ceftriaxone and doxycycline for suspected CNS infections could improve patient survival in Laos. [ABSTRACT FROM AUTHOR]
Copyright of Emerging Infectious Diseases is the property of Centers for Disease Control & Prevention (CDC) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:10806040
DOI:10.3201/eid2505.180914